Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease. [Phase 4]
Phase 4 trial evaluating ocrelizumab for prevention of clinical multiple sclerosis in individuals with radiologically isolated syndrome was …
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: PTNS for Female Patients Suffering From Multiple Sclerosis [NA]
Terminated clinical trial evaluating percutaneous tibial nerve stimulation (PTNS) in female patients with multiple sclerosis (including over…
-
FDA approval · 2024-10-08FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s supplemental ANDA for a generic version of dimethyl fumarate. The product is indicated for relapsing forms of …
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication [NA]
An ongoing clinical trial is recruiting to evaluate the efficacy of a Split Gait approach for treating dynamic gait asymmetries in subjects …
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis
A clinical trial by Amsterdam UMC is validating digital biomarkers to detect disease activity and progression in multiple sclerosis. The stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Systems Approach to Understanding Disease Processes in Multiple Sclerosis
This completed clinical trial reports a systems biology approach to understanding the disease processes underlying multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises [NA]
A completed clinical trial evaluating the effects of local vibration applied to different regions and spinal stabilization exercises in indi…
-
FDA approval · 2024-10-01FDA Tentative Approval: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA issued tentative approval for a supplemental application for Fingolimod by XLCare Pharmaceuticals Inc., enabling a generic version to en…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis [Phase 4]
Phase 4 trial comparing botulinum toxin A with anticholinergic therapy for neurogenic bladder in patients with multiple sclerosis has been t…
-
CLINICAL_TRIALS other · 2024-09-26Clinical Trial Update: OFSEP High Definition Cohort
The OFSEP High Definition Cohort trial related to Multiple Sclerosis is currently active but not recruiting, according to ClinicalTrials.gov…
-
FDA approval · 2024-09-25FDA Approved: GLATIRAMER ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original Abbreviated New Drug Application for glatiramer acetate, a generic version of Copax…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
This update reports results from the extension of the DISCOMS study, evaluating outcomes after discontinuation of disease-modifying therapie…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Pilates, Yoga and Tai Chi Exercises' Effect on Balance and Gait in Patients With Multiple Sclerosis [NA]
This clinical trial will evaluate the effects of Pilates, Yoga, and Tai Chi on balance and gait in people with multiple sclerosis, and is no…
-
FDA approval · 2024-09-25FDA Approved: GLATIRAMER ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original ANDA for glatiramer acetate, a generic version of the multiple sclerosis treatment.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Fatigue Management Programs for People With MS [NA]
This clinical trial update reports on fatigue management programs for people with multiple sclerosis; the study is completed and results hav…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) [NA]
This clinical trial is evaluating the efficacy and safety of Calculus Bovis Sativus (CBS) for idiopathic inflammatory demyelinating diseases…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device [NA]
This clinical trial update describes an exercise rehabilitation program for people with multiple sclerosis who use wheelchairs as their prim…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
Completed clinical trial evaluating multimodal evoked potentials as a predictor of disease progression in multiple sclerosis, aiming to vali…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS? [NA]
A completed University of Alberta–sponsored clinical trial explored whether reducing sedentary behavior could help manage comorbidity in ind…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden
This completed clinical study from Lille Catholic University investigates how disability in multiple sclerosis affects patients and caregive…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Ultra-high-field Brain MRI in Multiple Sclerosis
A clinical trial evaluating ultra-high-field brain MRI in individuals with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis [NA]
Clinical trial update on using patient-reported outcomes to improve care for people with multiple sclerosis, including associated anxiety an…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants
A clinical trial studying end-of-dose phenomena in subcutaneous natalizumab-treated multiple sclerosis participants has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Effect of Iyengar Yoga Practice on Patients with Multiple Sclerosis [NA]
This clinical trial (NCT05247372) studying the effects of Iyengar Yoga on individuals with Multiple Sclerosis has completed. The study inves…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Effect of Nurse Practitioner (NP-led) Care Upon Mood in People With Multiple Sclerosis [NA]
This entry reports on a completed clinical trial examining the impact of nurse practitioner-led care on mood in individuals with multiple sc…